Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies

por Kawalerski, Ryan R., Leach, Steven D., Escobar-Hoyos, Luisa F.
Publicado 2021

Dissecting the Oncogenic Roles of Keratin 17 in the Hallmarks of Cancer

por Baraks, Gabriella, Tseng, Robert, Pan, Chun-Hao, Kasliwal, Saumya, Leiton, Cindy V., Shroyer, Kenneth R., Escobar-Hoyos, Luisa F.
Publicado 2022

The origins and consequences of UPF1 variants in pancreatic adenosquamous carcinoma

por Polaski, Jacob T, Udy, Dylan B, Escobar-Hoyos, Luisa F, Askan, Gokce, Leach, Steven D, Ventura, Andrea, Kannan, Ram, Bradley, Robert K
Publicado 2021

Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer

por Roa-Peña, Lucia, Leiton, Cindy V., Babu, Sruthi, Pan, Chun-Hao, Vanner, Elizabeth A., Akalin, Ali, Bandovic, Jela, Moffitt, Richard A., Shroyer, Kenneth R., Escobar-Hoyos, Luisa F.
Publicado 2019

An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer

por Pan, Chun‐Hao, Otsuka, Yuka, Sridharan, BanuPriya, Woo, Melissa, Leiton, Cindy V., Babu, Sruthi, Torrente Gonçalves, Mariana, Kawalerski, Ryan R., K. Bai, Ji Dong, Chang, David K., Biankin, Andrew V., Scampavia, Louis, Spicer, Timothy, Escobar‐Hoyos, Luisa F., Shroyer, Kenneth R.
Publicado 2020